The Foundation for the National Institutes of Health (FNIH) is an organization that creates and leads alliances and public-private partnerships to support biomedical research, fighting disease in the United States…
Read More
It’s been a big year for Koneksa. We completed our Series B fundraising, securing $16 million to further investment in our industry-leading digital biomarker platform. We completed our work to…
Earlier this month, the European Medicines Agency (EMA)’s Human Medicines Division issued “Questions and Answers: Qualification of Digital Technology-Based Methodologies to Support Approval of Medicinal Products.” The Q&A explains considerations...
Read More
In early March, Koneksa’s Chief Scientific Officer, Elena Izmailova, Ph.D., presented at the pre-conference workshop “Digital Medicine 101” and shared the results of Koneksa work at the “Digital Tools Enabling…
Recently, Koneksa’s CEO Chris Benko and I had the opportunity to participate – and I had the opportunity to present – at a workshop on “Remote Digital Monitoring for Medical…
CAMBRIDGE, Mass. & NEW YORK–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and Koneksa Health, Inc. (“Koneksa”), an early stage company focused on the integration of real world data into clinical research,...
Read More
